CJC-1295 (without DAC) Peptide
CJC-1295 (without DAC) Peptide
$60.00 $77.00Price range: $60.00 through $77.00 Select options

CJC-1295 (without DAC) Peptide

Price range: $60.00 through $77.00

High-purity CJC-1295 without DAC is designed for advanced GHRH receptor and pulsatile growth hormone research. CJC-1295 without DAC (modified GRF 1-29), a tetrasubstituted GHRH analog, is widely utilized in scientific studies exploring short-acting pituitary stimulation, synergistic GH dynamics, and somatotropic axis mechanisms in pre-clinical models. For Research Use Only. Not for human use.

For Research Use Only — Not for Human Consumption
 

Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

CJC-1295 without DAC is a synthetic GHRH analog extensively used in preclinical research to investigate time-limited receptor activation, cAMP-mediated GH secretion, and natural-like pulsatile release patterns. This research-grade peptide is produced under stringent GMP-compliant conditions and provided as a lyophilized powder to ensure superior purity, stability, and reliability in experimental applications. For Research Use Only. Not for human use.

Engineered solely for preclinical investigations, each batch of CJC-1295 without DAC undergoes a comprehensive quality assessment and includes complete documentation, including a Certificate of Analysis (COA), purity data, and structural verification. As described in peer-reviewed literature, CJC-1295 without DAC is a synthetic analog of growth hormone-releasing hormone (GHRH) studied for its role in pulsatile GH secretion dynamics in laboratory models (academic.oup.com).

Scientific Overview

CJC-1295 without DAC binds to GHRH receptors, stimulating pituitary somatotrophs, and exhibits a short half-life in research settings. Preclinical investigations examine CJC-1295 without DAC in the following in vitro and in vivo laboratory contexts:

  • Transient GH release via adenylyl cyclase and cAMP elevation in pituitary models
  • Synergistic amplification of GH pulses when combined with GHRP compounds in rodent models
  • Maintenance of somatostatin-mediated negative feedback in acute laboratory protocols
  • IGF-1 axis modulation studies in controlled preclinical settings
  • Short-term endocrine signaling investigations in experimental models

Research-Referenced Functional Attributes (Based on existing preclinical and literature data — not intended as claims of therapeutic use)

  • Activation of GHRH receptors leading to time-limited GH secretion in pituitary cell cultures (DOI: 10.1210/en.2005-0664 related GRF analogs)
  • Synergistic GH release with GHRP compounds in rodent models (DOI: 10.1210/jc.2004-1719)
  • Preservation of natural pulsatile patterns and feedback inhibition in acute administration studies
  • Support for investigations into short-acting somatotropic signaling without sustained exposure
  • Examination of IGF-1 responses in controlled preclinical protocols
  • Examination of receptor desensitization dynamics in short-duration laboratory models

Why Researchers Choose Our CJC-1295 without DAC

For laboratories requiring dependable CJC-1295 without DAC research peptide, our manufacturing process prioritizes reproducibility and scientific precision. Every batch is confirmed for:

  • Purity ≥99% by HPLC
  • Structural identity via mass spectrometry
  • Third-party Certificate of Analysis (COA) available per lot

For Research Use Only. Not for human use. This product is a research chemical intended solely for laboratory and preclinical research purposes. It is not intended for administration to humans or animals.

Additional information

Weight .125 lbs
Dimensions 9 × 7 × .5 in
Size: No selection

5mg, 10mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.